| Title: |
544 A phase I/II clinical trial of anti-CLDN18.2/PD-L1 recombinant humanized bispecific antibody Q-1802 combined with XELOX chemotherapy in untreated advanced GC/GEJ patients |
| Authors: |
Wang, Yakun; Gong, Jifang; Yang, Jianwei; Sun, Yuping; Ni, Shuqin; Zhang, Yanqiao; Yang, Wenhui; Yang, Liu; Zhang, Yiwen; Li, Jiayi; Shi, Jinsheng; Zhao, Hongying; Liu, Tianshu; Pan, Hongming; Zhang, Jingdong; Deng, Yanhong; Kou, Xiaoge; Nie, Peng; Chen, Ye; Qu, Xiangdong; Shen, Lin |
| Source: |
Regular and Young Investigator Award Abstracts ; page A620-A620 |
| Publisher Information: |
BMJ Publishing Group Ltd |
| Publication Year: |
2025 |
| Document Type: |
conference object |
| Language: |
unknown |
| DOI: |
10.1136/jitc-2025-sitc2025.0544 |
| DOI: |
10.1136/jitc-2025-SITC2025.0544 |
| Availability: |
https://doi.org/10.1136/jitc-2025-sitc2025.0544; https://syndication.highwire.org/content/doi/10.1136/jitc-2025-SITC2025.0544 |
| Rights: |
http://creativecommons.org/licenses/by-nc/4.0/ |
| Accession Number: |
edsbas.8E367ED0 |
| Database: |
BASE |